Mode
Text Size
Log in / Sign up
Phase 2 N=23 Randomized Treatment

Yoga Cancer Rehabilitation Study: A Randomized Trial of Adaptive Yoga for Older Cancer Survivors

Neoplasms

Enrolled (actual)
23
Serious AEs
0.0%
Results posted
May 2015
Primary outcome: Primary: Patient-Reported Outcomes Measurement System Scale, a Scale Developed by the National Institute of Health to Assess Outcomes Across Different Trials. — 8.90; 12.26; 19.80; 16.80 units on a scale — p=.004

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Yoga therapy (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Apr 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
Patient-Reported Outcomes Measurement System Scale, a Scale Developed by the National Institute of Health to Assess Outcomes Across Different Trials.
8.90; 12.26; 19.80; 16.80; 12.41; 13.00 .004 sig

Summary

With advances in the detection and treatment of cancer, there are now 14 million cancer survivors in the U.S., 500,000 of whom are treated in the Veterans Health Administration. The mental and physical health consequences of cancer and its treatment may affect a Veteran's functioning and re-integration back into family, work, and daily life. Recent studies suggest that yoga may be an effective intervention for improving both the physical and mental health of individuals after cancer, although this has not been studied in Veterans. This study has three components: (1) Determine factors that increase participation in Yoga by Veterans using individual interviews and focus group; (2) Create a Yoga protocol for Veterans adapted from an existing empirically supported treatment, akin to a phase 1 clinical trial for safety and tolerability; (3) Evaluate the efficacy of Yoga for improving fatigue, insomnia, anxiety, and depression after treatment for colorectal cancer, akin to a phase 2 trial with randomization.

Eligibility Criteria

Inclusion Criteria

  • Cancer treated in the past 3 years

Exclusion Criteria

  • Dementia
  • Psychotic Disorder
  • In hospice care
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01324102). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search